{"id":10635,"date":"2015-04-08T14:07:41","date_gmt":"2015-04-08T14:07:41","guid":{"rendered":"http:\/\/nasadad.wpengine.com\/?p=10635"},"modified":"2015-04-08T14:12:39","modified_gmt":"2015-04-08T14:12:39","slug":"presentations-from-the-csat-sota-meeting-at-aatod-2","status":"publish","type":"post","link":"https:\/\/nasadad.org\/2015\/04\/presentations-from-the-csat-sota-meeting-at-aatod-2\/","title":{"rendered":"Presentations from the CSAT-SOTA Meeting at AATOD"},"content":{"rendered":"<p>At the 2015 AATOD Conference, SAMHSA staff and State Opioid Treatment Authorities (SOTAs) convened a day-long meeting to share information and discuss topics of interest to both SAMHSA and the States concerning opioid treatment and regulating Opioid Treatment Programs (OTPs). <!--more--><\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/nasadad.org\/2015\/04\/csatsota-pre-conference-session-agenda\/\">AGENDA<\/a><\/p>\n<p><strong>Heroin and Prescription Opioids<\/strong><\/p>\n<ul>\n<li><a href=\"http:\/\/nasadad.org\/?p=10631\">Hilary Jacobs (MA): Opioid Crisis in New England<\/a><\/li>\n<li><a href=\"http:\/\/nasadad.org\/?p=10632\">Mark Fisher (KY): Heroin Addiction in Kentucky<\/a><\/li>\n<li><a href=\"http:\/\/nasadad.org\/?p=10633\">Cheryl Marcum (MO): Opioid Dependence in Missouri<\/a><\/li>\n<\/ul>\n<p><strong>Mid-Level Practitioners &#8211; New Guidance on Exemption Requests<\/strong><\/p>\n<ul>\n<li><a href=\"http:\/\/nasadad.org\/?p=10636\">Melinda Campopiano, MD (SAMHSA): New Federal Guidelines for Opioid Treatment Programs<\/a><\/li>\n<\/ul>\n<p><strong>Performance Measures for MAT\/OTP<\/strong><\/p>\n<ul>\n<li><a href=\"http:\/\/nasadad.org\/?p=10637\">Dona Dmitrovic (OptumHealth Behavioral Solutions): Public Health Crisis &#8211; A Managed Care Response<\/a><\/li>\n<li><a href=\"http:\/\/nasadad.org\/?p=10638\">Hilary Jacobs (MA): Data Utilization<\/a><\/li>\n<li><a href=\"http:\/\/nasadad.org\/?p=10639\">Stacy Chamberlain (KS): Methadone and Managed Care<\/a><\/li>\n<\/ul>\n<p><strong>Health Homes &#8211; Primary Care Integration, Rural Treatment Issues<\/strong><\/p>\n<ul>\n<li><a href=\"http:\/\/nasadad.org\/?p=10640\">Susan A. Storti, PhD: Opioid Treatment Program Health Home Initiative<\/a><\/li>\n<li><a href=\"http:\/\/nasadad.org\/?p=10641\">Yngvild Olsen, MD; Lisa Hadley, MD (MD): Health Homes in Maryland<\/a><\/li>\n<li><a href=\"http:\/\/nasadad.org\/?p=10642\">Tony Folland (VT): Vermont Hub and Spoke Model for OTPs as Health Homes<\/a><\/li>\n<\/ul>\n<p><strong>Buprenorphine &#8211; State Regulation and Oversight<\/strong><\/p>\n<ul>\n<li><a href=\"http:\/\/nasadad.org\/?p=10643\">Brad DeCamp (OH): Expanding Authority for MAT, New Initiatives and Next Steps<\/a><\/li>\n<li><a href=\"http:\/\/nasadad.org\/?p=10644\">Tony Folland (VT): Buprenorphine in Vermont<\/a><\/li>\n<li><a href=\"http:\/\/nasadad.org\/?p=10645\">Marc Fishman, MD: Opioid Addiction Treatment &#8211; Challenges (and Opportunities) for Community Practice<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>At the 2015 AATOD Conference, SAMHSA staff and State Opioid Treatment Authorities (SOTAs) convened a day-long meeting to share information and discuss topics of interest to both SAMHSA and the States concerning opioid treatment and regulating Opioid Treatment Programs (OTPs).<\/p>\n","protected":false},"author":489,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ub_ctt_via":"","spay_email":"","footnotes":""},"categories":[18,29,68],"tags":[157],"class_list":["post-10635","post","type-post","status-publish","format-standard","hentry","category-news","category-otn","category-publicview","tag-aatod"],"featured_image_src":null,"author_info":{"display_name":"aaa","author_link":"https:\/\/nasadad.org\/author\/aaa_test_user\/"},"acf":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p73gOt-2Lx","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/nasadad.org\/wp-json\/wp\/v2\/posts\/10635"}],"collection":[{"href":"https:\/\/nasadad.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nasadad.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nasadad.org\/wp-json\/wp\/v2\/users\/489"}],"replies":[{"embeddable":true,"href":"https:\/\/nasadad.org\/wp-json\/wp\/v2\/comments?post=10635"}],"version-history":[{"count":0,"href":"https:\/\/nasadad.org\/wp-json\/wp\/v2\/posts\/10635\/revisions"}],"wp:attachment":[{"href":"https:\/\/nasadad.org\/wp-json\/wp\/v2\/media?parent=10635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nasadad.org\/wp-json\/wp\/v2\/categories?post=10635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nasadad.org\/wp-json\/wp\/v2\/tags?post=10635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}